{"id":"https://openalex.org/W4367304585","doi":"https://doi.org/10.1212/wnl.0000000000201762","title":"Characteristics of Multiple Sclerosis Patients by Phenotype: A Cross-Sectional Analysis Using the CLIMB Study (P5-3.006)","display_name":"Characteristics of Multiple Sclerosis Patients by Phenotype: A Cross-Sectional Analysis Using the CLIMB Study (P5-3.006)","publication_year":2023,"publication_date":"2023-04-25","ids":{"openalex":"https://openalex.org/W4367304585","doi":"https://doi.org/10.1212/wnl.0000000000201762"},"language":"en","primary_location":{"id":"doi:10.1212/wnl.0000000000201762","doi":"https://doi.org/10.1212/wnl.0000000000201762","is_oa":false,"landing_page_url":"https://doi.org/10.1212/wnl.0000000000201762","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5042755336","display_name":"Gauruv Bose","orcid":"https://orcid.org/0000-0002-5204-6348","observed_orcids":["https://orcid.org/0000-0002-5204-6348"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I153718931","display_name":"University of Ottawa","ror":"https://ror.org/03c4mmv16","country_code":"CA","type":"education","lineage":["https://openalex.org/I153718931"]},{"id":"https://openalex.org/I4388482656","display_name":"Ottawa Hospital Research Institute","ror":"https://ror.org/05jtef216","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I153718931","https://openalex.org/I2800722420","https://openalex.org/I4388482656"]}],"countries":["CA","US"],"is_corresponding":false,"raw_author_name":"Gauruv Bose","raw_affiliation_strings":["Brigham and Women\u2019s Hospital; and University of Ottawa and Ottawa Hospital Research Institute","Brigham and Women's Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Brigham and Women\u2019s Hospital; and University of Ottawa and Ottawa Hospital Research Institute","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I153718931","https://openalex.org/I4388482656"]},{"raw_affiliation_string":"Brigham and Women's Hospital","institution_ids":["https://openalex.org/I1283280774"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108837940","display_name":"Nupur Greene","orcid":"https://orcid.org/0009-0001-2322-6016","observed_orcids":["https://orcid.org/0009-0001-2322-6016"]},"institutions":[{"id":"https://openalex.org/I3018075036","display_name":"Sanofi (France)","ror":"https://ror.org/02n6c9837","country_code":"FR","type":"company","lineage":["https://openalex.org/I3018075036"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Nupur Greene","raw_affiliation_strings":["Sanofi"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sanofi","institution_ids":["https://openalex.org/I3018075036"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043858638","display_name":"Brian C. Healy","orcid":"https://orcid.org/0000-0001-5272-2425","observed_orcids":["https://orcid.org/0000-0001-5272-2425"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brian Healy","raw_affiliation_strings":["Brigham and Women's Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Brigham and Women's Hospital","institution_ids":["https://openalex.org/I1283280774"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069092257","display_name":"Howard L. Weiner","orcid":"https://orcid.org/0000-0003-0203-9681","observed_orcids":["https://orcid.org/0000-0003-0203-9681"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Howard Weiner","raw_affiliation_strings":["Brigham and Women's Hospital and Harvard Medical School"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Brigham and Women's Hospital and Harvard Medical School","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005536370","display_name":"Lisa E. Farnett","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3018075036","display_name":"Sanofi (France)","ror":"https://ror.org/02n6c9837","country_code":"FR","type":"company","lineage":["https://openalex.org/I3018075036"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Lisa Farnett","raw_affiliation_strings":["Sanofi"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sanofi","institution_ids":["https://openalex.org/I3018075036"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103388634","display_name":"Keiko Higuchi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3018075036","display_name":"Sanofi (France)","ror":"https://ror.org/02n6c9837","country_code":"FR","type":"company","lineage":["https://openalex.org/I3018075036"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Keiko Higuchi","raw_affiliation_strings":["Sanofi"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sanofi","institution_ids":["https://openalex.org/I3018075036"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5055725062","display_name":"Tanuja Chitnis","orcid":"https://orcid.org/0000-0002-9897-4422","observed_orcids":["https://orcid.org/0000-0002-9897-4422"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tanuja Chitnis","raw_affiliation_strings":["Brigham and Women's Hospital and Harvard Medical School"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Brigham and Women's Hospital and Harvard Medical School","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.3233,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.51065759,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"100","issue":"17_supplement_2","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11827","display_name":"Polyomavirus and related diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multiple-sclerosis","display_name":"multiple sclerosis","score":0.9670000076293945},{"id":"https://openalex.org/keywords/ms-phenotype","display_name":"MS phenotype","score":0.8539999723434448},{"id":"https://openalex.org/keywords/relapsing-remitting-multiple-sclerosis","display_name":"relapsing-remitting multiple sclerosis","score":0.9879999756813049},{"id":"https://openalex.org/keywords/primary-progressive-multiple-sclerosis","display_name":"primary progressive multiple sclerosis","score":0.9800000190734863},{"id":"https://openalex.org/keywords/secondary-progressive-multiple-sclerosis","display_name":"secondary progressive multiple sclerosis","score":0.9290000200271606},{"id":"https://openalex.org/keywords/disability-progression","display_name":"disability progression","score":0.4830000102519989},{"id":"https://openalex.org/keywords/expanded-disability-status-scale","display_name":"Expanded Disability Status Scale","score":0.9819999933242798},{"id":"https://openalex.org/keywords/disease-modifying-therapy","display_name":"disease-modifying therapy","score":0.6769999861717224},{"id":"https://openalex.org/keywords/treatment-initiation-timing","display_name":"treatment initiation timing","score":0.4180000126361847},{"id":"https://openalex.org/keywords/disease-duration","display_name":"disease duration","score":0.8410000205039978},{"id":"https://openalex.org/keywords/phenotype-transition","display_name":"phenotype transition","score":0.4399999976158142},{"id":"https://openalex.org/keywords/patient-reported-outcomes","display_name":"patient-reported outcomes","score":0.36399999260902405}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7919211387634277},{"id":"https://openalex.org/C2780640218","wikidata":"https://www.wikidata.org/wiki/Q8277","display_name":"Multiple sclerosis","level":2,"score":0.6872566342353821},{"id":"https://openalex.org/C2780084366","wikidata":"https://www.wikidata.org/wiki/Q37732","display_name":"Demographics","level":2,"score":0.5931715965270996},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.5725365281105042},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5534932613372803},{"id":"https://openalex.org/C2780892749","wikidata":"https://www.wikidata.org/wiki/Q929518","display_name":"Expanded Disability Status Scale","level":3,"score":0.49924683570861816},{"id":"https://openalex.org/C1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","level":1,"score":0.39745938777923584},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.39690154790878296},{"id":"https://openalex.org/C149923435","wikidata":"https://www.wikidata.org/wiki/Q37732","display_name":"Demography","level":1,"score":0.19277077913284302},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.09053155779838562},{"id":"https://openalex.org/C144024400","wikidata":"https://www.wikidata.org/wiki/Q21201","display_name":"Sociology","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1212/wnl.0000000000201762","doi":"https://doi.org/10.1212/wnl.0000000000201762","is_oa":false,"landing_page_url":"https://doi.org/10.1212/wnl.0000000000201762","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4367305257","https://openalex.org/W7202371360","https://openalex.org/W3206244403","https://openalex.org/W4282015733","https://openalex.org/W2766465613","https://openalex.org/W3008827026","https://openalex.org/W1910156832","https://openalex.org/W2048132365","https://openalex.org/W7161496976","https://openalex.org/W1903183715"],"abstract_inverted_index":{"Objective:":[0],"To":[1],"investigate":[2],"how":[3,42,48],"multiple":[4],"sclerosis":[5],"(MS)":[6],"prevalence":[7],"and":[8,25,47,89,175,214,228,240,268,276],"characteristics":[9,43,49],"vary":[10,44],"across":[11,45],"different":[12],"MS":[13,21,31,85,99,102,106,110,166,590],"phenotypes":[14,35,204],"within":[15],"the":[16,23,52,78,252,402,420,439,458,484,509,534,546,775,793,811],"Comprehensive":[17],"Longitudinal":[18],"Investigation":[19],"of":[20,54,58,77,160,211,305,316,326,338,350,363,374,386,404,422,441,460,486,511,536,545,548,567,577,581,594,606,619,633,655,674,687,700,715,730,777,795,813,826,837,848],"at":[22,51,95,165,223],"Brigham":[24],"Women\u2019s":[26],"Hospital":[27],"(CLIMB)":[28],"Study.":[29],"Background:":[30],"is":[32,57],"categorized":[33],"into":[34],"based":[36,92],"on":[37,93,282,464,490,515,817],"its":[38],"clinical":[39,295],"course.":[40],"Understanding":[41],"phenotype,":[46,265],"change":[50],"time":[53],"phenotype":[55,94],"transition":[56],"interest,":[59],"as":[60,408,426,445,540,652,671,684,697,712,727,781,799],"treatment":[61,72,201,275],"intervention":[62],"at,":[63],"or":[64,131,468,494,519,543,558,740,751,762],"prior":[65],"to":[66,190,199,280,322],"this":[67,257],"stage,":[68],"may":[69],"impact":[70],"long-term":[71],"outcomes.":[73],"Design/Methods:":[74],"Retrospective":[75],"analysis":[76],"US-based":[79],"CLIMB":[80],"Study":[81],"identified":[82,255],"people":[83],"with":[84,266,299],"(pwMS)":[86],"(aged":[87],"18\u201365y),":[88],"stratified":[90],"them":[91],"\u201cindex\u201d":[96],"(Dec-22-2021):":[97],"relapsing-remitting":[98],"[RRMS],":[100],"primary-progressive":[101],"[PPMS],":[103],"active":[104],"secondary-progressive":[105,109],"[aSPMS],":[107],"non-relapsing":[108],"[nrSPMS].":[111],"Demographics":[112],"were":[113,125,162,218,233],"extracted":[114],"alongside":[115],"disability":[116,286],"scores":[117,232],"(Expanded":[118],"Disability":[119],"Status":[120],"Scale":[121],"[EDSS]).":[122],"Between-group":[123],"differences":[124],"calculated":[126],"using":[127],"chi-square":[128],"(categorical":[129],"variables)":[130,136],"Kruskal-Wallis":[132],"by":[133,264],"ranks":[134],"(continuous":[135],"tests.":[137],"Data":[138,469,495,520],"are":[139],"presented":[140],"mean\u00b1SD.":[141],"Results:":[142],"The":[143,209,303,324,336,348,361,372,384,565,579,592,604,617,631,824,835,846],"analyzed":[144],"cohort":[145],"(n=2,599":[146],"pwMS)":[147],"included:":[148],"RRMS,":[149],"n=1,891[72.8%];":[150],"PPMS,":[151],"n=133[5.1%];":[152],"nrSPMS,":[153],"n=534[20.5%];":[154],"aSPMS,":[155],"n=41[1.6%]":[156],"patients.":[157,290],"Overall,":[158],"46.6%\u201375.9%":[159],"cohorts":[161],"female.":[163],"Age":[164],"onset":[167],"was":[168],"lower":[169],"for":[170,235,244,273,406,411,424,429,443,448,462,473,488,499,513,524,538,550,650,669,682,695,710,725,779,784,797,802,815,821],"aSPMS":[171,212,241],"(32.2\u00b112.7y),":[172],"RRMS":[173,193,215,245,289],"(32.6\u00b19.7y),":[174],"nrSPMS":[176,226,236,267],"(33.8\u00b110.4y)":[177],"vs.":[178,202,206,225,288],"PPMS":[179,229,238,269],"(44.4\u00b110.7y;":[180],"P<0.001).":[181,208,247],"Disease":[182],"duration":[183,198],"(at":[184],"index)":[185],"ranged":[186],"from":[187,312,333,345,357,370,381,393,562,574,588,601,613,626,640,744,755,766,833,844,855],"16.2\u00b19.9y":[188],"(RRMS)":[189],"26.1\u00b111.8y":[191],"(nrSPMS).":[192],"patients":[194,217,270,298],"had":[195,260],"a":[196,409,427,446,465,491,516,782,800,818],"shorter":[197],"first":[200,274],"other":[203],"(4.2y":[205],"7.2\u20139.4y;":[207],"majority":[210],"(61.0%)":[213],"(68.7%)":[216],"receiving":[219],"disease-modifying":[220],"therapies":[221],"(DMTs)":[222],"index":[224],"(58.2%)":[227],"(51.9%).":[230],"EDSS":[231],"higher":[234,285],"(5.9\u00b11.8),":[237,239],"(5.7\u00b11.9),":[242],"than":[243],"(1.9\u00b11.5;":[246],"Conclusions:":[248],"Among":[249],"pwMS":[250],"in":[251,256,401,419,438,457,483,508,533,661,774,792,810],"United":[253],"States":[254],"cohort,":[258],"20.5%":[259],"nrSPMS.":[261],"Characteristics":[262],"varied":[263],"waiting":[271],"longer":[272],"being":[277],"less":[278],"likely":[279],"be":[281],"DMTs,":[283],"despite":[284],"burden":[287],"This":[291],"highlights":[292],"an":[293,541,559,653,672,685,698,713,728,741,752,763],"unmet":[294],"need":[296],"among":[297],"progressive":[300],"MS.":[301],"Disclosure:":[302],"institution":[304,325,337,349,362,373,385,566,580,593,605,618,632,825,836,847],"Dr.":[306,395,413,432,451,477,502,527,553,568,582,595,607,620,634,768,786,804,827,838,849],"Bose":[307],"has":[308,320,329,341,353,366,377,389,397,415,434,453,479,504,529,555,570,584,597,609,622,636,646,659,665,678,691,706,721,737,748,759,770,788,806,829,840,851],"received":[309,330,342,354,367,378,390,398,416,435,454,480,505,530,556,571,585,598,610,623,637,647,666,679,692,707,722,738,749,760,771,789,807,830,841,852],"research":[310,331,343,355,368,379,391,572,586,599,611,624,638,831,842,853],"support":[311,332,344,356,369,380,392,573,587,600,612,625,639,832,843,854],"Multiple":[313],"Sclerosis":[314],"Society":[315],"Canada.":[317],"Nupur":[318],"Greene":[319],"nothing":[321],"disclose.":[323],"Mr.":[327,339,351,364,375,387],"Healy":[328,340,352,365,376,388],"Analysis":[334],"Group.":[335],"Bristol-Myers":[346],"Squibb.":[347],"Verily":[358,627],"Life":[359,475,628],"Sciences.":[360,476],"Novartis.":[371,688,767,785,834],"Merck":[382],"Serono.":[383],"Genzyme.":[394],"Weiner":[396,414,433,452,478,503,528,554,569,583,596,608,621,635],"personal":[399,417,436,455,481,506,531,648,667,680,693,708,723,772,790,808],"compensation":[400,418,437,456,482,507,532,649,668,681,694,709,724,773,791,809],"range":[403,421,440,459,485,510,535,776,794,812],"$500-$4,999":[405,423,814],"serving":[407,425,444,463,489,514,539,651,670,683,696,711,726,780,798,816],"Consultant":[410,428,447,783,801],"Genentech.":[412],"Medday":[430,525],"Pharmaceuticals.":[431,526],"$10,000-$49,999":[442,487,512,537,778],"vTv":[449,500,551,563],"Therapeutics.":[450,501,552,564],"$5,000-$9,999":[461,796],"Scientific":[466,492,517],"Advisory":[467,493,518],"Safety":[470,496,521],"Monitoring":[471,497,522],"board":[472,498,523],"Tiziana":[474],"officer":[542],"member":[544],"Board":[547],"Directors":[549],"stock":[557,660,739,750,761],"ownership":[560,742,753,764],"interest":[561,743,754,765],"National":[575,589],"Institute":[576],"Health.":[578],"Society.":[591],"Genzyme":[602],"Corp.":[603],"Genentech,":[614],"Inc.":[615,717,733],".":[616,703,718,734],"Sciences":[629,702],"LLC.":[630],"EMD":[641],"Serono,":[642],"Inc..":[643],"Ms.":[644,657],"Farnett":[645,658],"employee":[654,673,686,699,714,729],"Sanofi.":[656,662,675,745,845],"Miss":[663,676,689,704,719,735,746,757],"Higuchi":[664,677,690,705,720,736,747,758],"Gilead":[701],"Pfizer":[716],"Zynx":[731],"Health":[732],"Gilead.":[756],"Chitnis":[769,787,805,828,839,850],"Roche-Genentech.":[803],"Speakers":[819],"Bureau":[820],"Academic":[822],"CME.":[823],"Octave.":[856]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":1}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2023-04-29T00:00:00"}